Fabrizio Marcucci

Summary

Country: Italy

Publications

  1. doi request reprint Improving drug penetration to curb tumor drug resistance
    Fabrizio Marcucci
    Centro Nazionale di Epidemiologia, sorveglianza e promozione della salute CNESPS, Istituto Superiore di Sanità ISS, Via Giano della Bella 34, 00162 Rome, Italy
    Drug Discov Today 17:1139-46. 2012
  2. doi request reprint How to improve exposure of tumor cells to drugs: promoter drugs increase tumor uptake and penetration of effector drugs
    Fabrizio Marcucci
    Centro Nazionale di Epidemiologia, sorveglianza e promozione della salute CNESPS, Istituto Superiore di Sanità ISS, Rome, Italy
    Adv Drug Deliv Rev 64:53-68. 2012
  3. doi request reprint Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities
    Fabrizio Marcucci
    Centro Nazionale di Epidemiologia, sorveglianza e promozione della salute CNESPS, Istituto Superiore di Sanità ISS, Rome, Italy
    Blood 117:1792-8. 2011
  4. ncbi request reprint High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma
    Fabrizio Marcucci
    Istituto Superiore di Sanita, Rome, Italy
    Haematologica 91:554-7. 2006
  5. ncbi request reprint Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study
    Elvira Bianco
    Istituto Superiore di Sanita, Rome, Italy
    Haematologica 89:70-6. 2004
  6. ncbi request reprint Rare HVR1-HCV genotype 1b variants in patients with B non Hodgkin's lymphoma. Comparison with viral sequences detected in cases of lymphoproliferative disorders and B cell compartmentalisation
    Stefano Dettori
    Viral Hepatitis Unit, Department of Infectious, Parasitic and Immune Mediated Disease, Istituto Superiore di Sanita, Rome
    New Microbiol 30:265-70. 2007
  7. ncbi request reprint Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study
    Alfonso Mele
    Istituto Superiore di Sanita, Rome La Sapienza University, Rome, Italy
    Blood 102:996-9. 2003
  8. pmc Approaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cells
    Fabrizio Marcucci
    Centro Nazionale di Epidemiologia, Sorveglianza e Promozione della Salute, Istituto Superiore di Sanita, Roma, Italy
    MAbs 5:34-46. 2013
  9. doi request reprint Pushing tumor cells towards a malignant phenotype: stimuli from the microenvironment, intercellular communications and alternative roads
    Fabrizio Marcucci
    Centro Nazionale di Epidemiologia Sorveglianza e Promozione della Salute CNESPS, Istituto Superiore di Sanità ISS, Roma, Italy Hepatology Association of Calabria ACE, Reggio Calabria, Italy
    Int J Cancer 135:1265-76. 2014
  10. ncbi request reprint Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress
    Fabrizio Marcucci
    Reparto di Epidemiologia Clinica, Istituto Superiore di Sanita, Viale Regina Elena 299, 00161 Rome, Italy
    Drug Discov Today 9:219-28. 2004

Collaborators

Detail Information

Publications10

  1. doi request reprint Improving drug penetration to curb tumor drug resistance
    Fabrizio Marcucci
    Centro Nazionale di Epidemiologia, sorveglianza e promozione della salute CNESPS, Istituto Superiore di Sanità ISS, Via Giano della Bella 34, 00162 Rome, Italy
    Drug Discov Today 17:1139-46. 2012
    ....
  2. doi request reprint How to improve exposure of tumor cells to drugs: promoter drugs increase tumor uptake and penetration of effector drugs
    Fabrizio Marcucci
    Centro Nazionale di Epidemiologia, sorveglianza e promozione della salute CNESPS, Istituto Superiore di Sanità ISS, Rome, Italy
    Adv Drug Deliv Rev 64:53-68. 2012
    ....
  3. doi request reprint Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities
    Fabrizio Marcucci
    Centro Nazionale di Epidemiologia, sorveglianza e promozione della salute CNESPS, Istituto Superiore di Sanità ISS, Rome, Italy
    Blood 117:1792-8. 2011
    ..Available evidence on the association with other hematologic malignancies is also addressed briefly...
  4. ncbi request reprint High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma
    Fabrizio Marcucci
    Istituto Superiore di Sanita, Rome, Italy
    Haematologica 91:554-7. 2006
    ..75-7.66). HBV/HCV co-infection was found in four cases, but in no controls. The finding of a positive association between HBV infection and B-NHL raises the possibility that HBV may play an etiologic role in the induction of B-NHL...
  5. ncbi request reprint Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study
    Elvira Bianco
    Istituto Superiore di Sanita, Rome, Italy
    Haematologica 89:70-6. 2004
    ..Little knowledge is, however, available on possible associations between HCV infection and other lymphoid or myeloid malignancies. The present study was set up in order to investigate this aspect...
  6. ncbi request reprint Rare HVR1-HCV genotype 1b variants in patients with B non Hodgkin's lymphoma. Comparison with viral sequences detected in cases of lymphoproliferative disorders and B cell compartmentalisation
    Stefano Dettori
    Viral Hepatitis Unit, Department of Infectious, Parasitic and Immune Mediated Disease, Istituto Superiore di Sanita, Rome
    New Microbiol 30:265-70. 2007
    ..In conclusion, the HCV predominants circulating in B-NHL cases seem to be associated with clonal selection of rare variants...
  7. ncbi request reprint Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study
    Alfonso Mele
    Istituto Superiore di Sanita, Rome La Sapienza University, Rome, Italy
    Blood 102:996-9. 2003
    ..The estimated AR was 4.6%. This study confirms an association between HCV and B-NHL. In Italy, 1 of 20 instances of B-NHL may be attributable to HCV infection and may, thus, benefit from antiviral treatment...
  8. pmc Approaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cells
    Fabrizio Marcucci
    Centro Nazionale di Epidemiologia, Sorveglianza e Promozione della Salute, Istituto Superiore di Sanita, Roma, Italy
    MAbs 5:34-46. 2013
    ..We also discuss future directions of research that might further improve the therapeutic efficacy of antitumor mAbs...
  9. doi request reprint Pushing tumor cells towards a malignant phenotype: stimuli from the microenvironment, intercellular communications and alternative roads
    Fabrizio Marcucci
    Centro Nazionale di Epidemiologia Sorveglianza e Promozione della Salute CNESPS, Istituto Superiore di Sanità ISS, Roma, Italy Hepatology Association of Calabria ACE, Reggio Calabria, Italy
    Int J Cancer 135:1265-76. 2014
    ..At the end of this review, we address some unanswered questions in this domain and indicate future directions of research. ..
  10. ncbi request reprint Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress
    Fabrizio Marcucci
    Reparto di Epidemiologia Clinica, Istituto Superiore di Sanita, Viale Regina Elena 299, 00161 Rome, Italy
    Drug Discov Today 9:219-28. 2004
    ..Recent findings, for example, the identification of cell-penetrating peptides with restricted cell selectivity, suggest that further improvements in this approach are likely in the near future...